VOYA Investment Management’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Sell |
38,312
-41,954
| -52% | -$143K | ﹤0.01% | 2423 |
|
|
2025
Q1 | $322K | Buy |
80,266
+40,517
| +102% | +$162K | ﹤0.01% | 2082 |
|
|
2024
Q4 | $258K | Sell |
39,749
-3,547
| -8% | -$23K | ﹤0.01% | 2275 |
|
|
2024
Q3 | $240K | Buy |
43,296
+1,679
| +4% | +$9.3K | ﹤0.01% | 2383 |
|
|
2024
Q2 | $232K | Buy |
41,617
+1,397
| +3% | +$7.8K | ﹤0.01% | 2394 |
|
|
2024
Q1 | $270K | Sell |
40,220
-9,241
| -19% | -$62K | ﹤0.01% | 2305 |
|
|
2023
Q4 | $451K | Buy |
49,461
+839
| +2% | +$7.65K | ﹤0.01% | 2130 |
|
|
2023
Q3 | $268K | Sell |
48,622
-262
| -0.5% | -$1.45K | ﹤0.01% | 2363 |
|
|
2023
Q2 | $417K | Sell |
48,884
-156,859
| -76% | -$1.34M | ﹤0.01% | 2192 |
|
|
2023
Q1 | $1.89M | Buy |
205,743
+45,390
| +28% | +$417K | ﹤0.01% | 1377 |
|
|
2022
Q4 | $1.64M | Buy |
160,353
+27,647
| +21% | +$282K | ﹤0.01% | 1416 |
|
|
2022
Q3 | $1.95M | Buy |
132,706
+89,829
| +210% | +$1.32M | ﹤0.01% | 1330 |
|
|
2022
Q2 | $460K | Buy |
+42,877
| New | +$460K | ﹤0.01% | 1886 |
|